Semaglutide is a GLP-1 receptor agonist that works by regulating blood sugar levels, slowing digestion, and reducing appetite
From a systems perspective, anxiety disorders is characterized by abnormalities in neurotransmitter functions, neurotrophic signaling, the endocannabinoid system and HPA axis function and these alterations are further compounded by chronic inflammation and maladaptive immune responses (Cai et al., 2025)
Essentially, glucagon-like peptide-1 (GLP-1) receptor agonists (RA) and glucose-dependent insulinotropic polypeptide (GLP-1/GIP) dual RA target the fundamental pathophysiology that underpins both T2D and obesity
Offer flexible treatment for both adults and pediatricsoral, injectable, and ODT forms for ease of use in all settings
Proc Natl Acad Sci 99: 2654-9
: , 0